Cargando…

What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?

The recommendations on the intake of long chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFA) vary from eating oily fish (“once to twice per week”) to consuming specified daily amounts of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (“250–500 mg per day”). It is not known if there...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemifard, Samaneh, Sinclair, Andrew J., Kaur, Gunveen, Lewandowski, Paul, Turchini, Giovanni M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517018/
https://www.ncbi.nlm.nih.gov/pubmed/26184297
http://dx.doi.org/10.3390/nu7075241
_version_ 1782383136030588928
author Ghasemifard, Samaneh
Sinclair, Andrew J.
Kaur, Gunveen
Lewandowski, Paul
Turchini, Giovanni M.
author_facet Ghasemifard, Samaneh
Sinclair, Andrew J.
Kaur, Gunveen
Lewandowski, Paul
Turchini, Giovanni M.
author_sort Ghasemifard, Samaneh
collection PubMed
description The recommendations on the intake of long chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFA) vary from eating oily fish (“once to twice per week”) to consuming specified daily amounts of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (“250–500 mg per day”). It is not known if there is a difference in the uptake/bioavailability between regular daily consumption of supplementsvs. consuming fish once or twice per week. In this study, the bioavailability of a daily dose of n-3 LC-PUFA (Constant treatment), representing supplements, vs. a large weekly dose of n-3 LC-PUFA (Spike treatment), representing consuming once or twice per week, was assessed. Six-week old healthy male Sprague-Dawley rats were fed either a Constant treatment, a Spike treatment or Control treatment (no n-3 LC-PUFA), for six weeks. The whole body, tissues and faeces were analysed for fatty acid content. The results showed that the major metabolic fate of the n-3 LC-PUFA (EPA+docosapentaenoic acid (DPA) + DHA) was towards catabolism (β-oxidation) accounting for over 70% of total dietary intake, whereas deposition accounted less than 25% of total dietary intake. It was found that significantly more n-3 LC-PUFA were β-oxidised when originating from the Constant treatment (84% of dose), compared with the Spike treatment (75% of dose). Conversely, it was found that significantly more n-3 LC-PUFA were deposited when originating from the Spike treatment (23% of dose), than from the Constant treatment (15% of dose). These unexpected findings show that a large dose of n-3 LC-PUFA once per week is more effective in increasing whole body n-3 LC-PUFA content in rats compared with a smaller dose delivered daily.
format Online
Article
Text
id pubmed-4517018
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-45170182015-07-30 What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil? Ghasemifard, Samaneh Sinclair, Andrew J. Kaur, Gunveen Lewandowski, Paul Turchini, Giovanni M. Nutrients Article The recommendations on the intake of long chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFA) vary from eating oily fish (“once to twice per week”) to consuming specified daily amounts of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (“250–500 mg per day”). It is not known if there is a difference in the uptake/bioavailability between regular daily consumption of supplementsvs. consuming fish once or twice per week. In this study, the bioavailability of a daily dose of n-3 LC-PUFA (Constant treatment), representing supplements, vs. a large weekly dose of n-3 LC-PUFA (Spike treatment), representing consuming once or twice per week, was assessed. Six-week old healthy male Sprague-Dawley rats were fed either a Constant treatment, a Spike treatment or Control treatment (no n-3 LC-PUFA), for six weeks. The whole body, tissues and faeces were analysed for fatty acid content. The results showed that the major metabolic fate of the n-3 LC-PUFA (EPA+docosapentaenoic acid (DPA) + DHA) was towards catabolism (β-oxidation) accounting for over 70% of total dietary intake, whereas deposition accounted less than 25% of total dietary intake. It was found that significantly more n-3 LC-PUFA were β-oxidised when originating from the Constant treatment (84% of dose), compared with the Spike treatment (75% of dose). Conversely, it was found that significantly more n-3 LC-PUFA were deposited when originating from the Spike treatment (23% of dose), than from the Constant treatment (15% of dose). These unexpected findings show that a large dose of n-3 LC-PUFA once per week is more effective in increasing whole body n-3 LC-PUFA content in rats compared with a smaller dose delivered daily. MDPI 2015-07-10 /pmc/articles/PMC4517018/ /pubmed/26184297 http://dx.doi.org/10.3390/nu7075241 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ghasemifard, Samaneh
Sinclair, Andrew J.
Kaur, Gunveen
Lewandowski, Paul
Turchini, Giovanni M.
What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?
title What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?
title_full What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?
title_fullStr What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?
title_full_unstemmed What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?
title_short What Is the Most Effective Way of Increasing the Bioavailability of Dietary Long Chain Omega-3 Fatty Acids—Daily vs. Weekly Administration of Fish Oil?
title_sort what is the most effective way of increasing the bioavailability of dietary long chain omega-3 fatty acids—daily vs. weekly administration of fish oil?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517018/
https://www.ncbi.nlm.nih.gov/pubmed/26184297
http://dx.doi.org/10.3390/nu7075241
work_keys_str_mv AT ghasemifardsamaneh whatisthemosteffectivewayofincreasingthebioavailabilityofdietarylongchainomega3fattyacidsdailyvsweeklyadministrationoffishoil
AT sinclairandrewj whatisthemosteffectivewayofincreasingthebioavailabilityofdietarylongchainomega3fattyacidsdailyvsweeklyadministrationoffishoil
AT kaurgunveen whatisthemosteffectivewayofincreasingthebioavailabilityofdietarylongchainomega3fattyacidsdailyvsweeklyadministrationoffishoil
AT lewandowskipaul whatisthemosteffectivewayofincreasingthebioavailabilityofdietarylongchainomega3fattyacidsdailyvsweeklyadministrationoffishoil
AT turchinigiovannim whatisthemosteffectivewayofincreasingthebioavailabilityofdietarylongchainomega3fattyacidsdailyvsweeklyadministrationoffishoil